Characterization of Airway Morphology in Post-infectious versus Post-lung Transplant Bronchiolitis Obliterans

Roel Martens1,2, Birgit Weynand1,2, Alexandra De Zutter3

  • 1Department of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.

Insights

Post-infectious bronchiolitis obliterans (PIBO) lungs show significantly fewer terminal bronchioles than bronchiolitis obliterans syndrome (BOS) lungs. Morphological differences in airway obstructions suggest dysanaptic lung growth in PIBO.

Area of Science:

  • Pulmonary Medicine
  • Pediatric Pulmonology
  • Thoracic Surgery

Background:

  • Post-infectious bronchiolitis obliterans (PIBO) can follow childhood infections.
  • Dysanaptic lung growth, characterized by differential alveolar and airway development, is a suspected but elusive consequence of PIBO.
  • This study investigates the airway morphology in PIBO compared to bronchiolitis obliterans syndrome (BOS).

Purpose of the Study:

  • To perform a detailed morphological characterization of the entire airway tree in PIBO.
  • To compare airway morphology in PIBO with that of bronchiolitis obliterans syndrome (BOS) and control lungs.
  • To identify structural evidence supporting the hypothesis of dysanaptic lung growth in PIBO.

Main Methods:

  • Ex vivo high-resolution computed tomography (CT) scans were used for 3D airway segmentation of lungs from PIBO, BOS, and control groups.
  • Micro-CT and histology were employed for 3D assessment of terminal bronchioles in lung tissue samples.
  • Quantitative analysis focused on airway number, diameter, obstruction, and terminal bronchiole characteristics.

Main Results:

  • Airway diameters were increased in both PIBO and BOS compared to controls, with no significant difference between PIBO and BOS.
  • PIBO lungs had significantly fewer terminal bronchioles (nearly threefold decrease) compared to BOS and controls.
  • Airway obstructions differed, being more numerous but smaller in BOS, and larger but less numerous in PIBO, with distinct patterns of pre-terminal bronchiole obstruction.

Conclusions:

  • PIBO lungs exhibit a substantial reduction in terminal bronchioles compared to BOS lungs.
  • Distinct morphological differences in airway obstruction type and location were observed between PIBO and BOS.
  • These findings provide structural evidence supporting dysanaptic lung growth as a consequence of PIBO.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.